Instructions

ZOOM IN by clicking on the page. A slider will appear, allowing you to adjust your zoom level. Return to the original size by clicking on the page again.

MOVE the page around when zoomed in by dragging it.

ADJUST the zoom using the slider on the top right.

ZOOM OUT by clicking on the zoomed-in page.

SEARCH by entering text in the search field and click on "In This Issue" or "All Issues" to search the current issue or the archive of back issues
respectively.

PRINT by clicking on thumbnails to select pages, and then press the
print button.

SHARE this publication and page.

ROTATE PAGE allows you to turn pages 90 degrees clockwise or counterclockwise.Click on the page to return to the original orientation. To zoom in on a rotated page, return the page to its original orientation, zoom in, and
then rotate it again.

CONTENTS displays a table of sections with thumbnails and descriptions.

ALL PAGES displays thumbnails of every page in the issue. Click on
a page to jump.

B Parncutt AO
Director since
April 2012
Responsibilities
Non-Executive Director, member of the Human Capital and Nomination Committee and Chair of the Audit
and Risk Committee with financial qualification.
Qualifications
BSc, MBA
Experience
Bruce joined the Board on 30 April 2012. His career spans over 40 years in investment management,
investment banking and stockbroking including seven years as Chief Executive of listed securities firm
Mclntosh Securities (1990 –1996) and three years as Senior Vice President of Merrill Lynch (1997–1999).
His experience includes extensive involvement in financial analysis, merger and acquisition transactions,
capital raisings, and investment in companies across a broad spectrum from early stage to mature public
companies. He holds a Bachelor of Science, MBA, and is a member of the Financial Services Institute of
Australasia. Bruce is Chairman of the investment and corporate advisory firm Lion Capital. He is a board
member of the Australian Ballet Company. His previous roles have included, Director of Australian Stock
Exchange Ltd and Vision Systems Ltd, President of The National Gallery of Victoria and member of
Council of Melbourne Grammar School.
T Oldham
Director since
October 2013
Responsibilities
Non-Executive Director, member of the Audit and Risk Committee and Chair of the Human Capital and
Nomination Committee (commencing July 2015)
Qualifications
BSc, (Hons), LLB(Hons), PhD
Experience
Tim joined the Board in October 2013. He has more than 15 years of life sciences business development,
alliance management and sales and marketing experience in Europe, Asia and Australia. He is CEO
and Managing Director of Cell Therapies Pty Ltd, a leading Asia Pacific provider of manufacturing and
distribution of cell-based therapeutics and was President of Asia Pacific for Hospira Inc. (2007–2012),
having held a variety of senior management roles with Mayne Pharma (2002 –2007) prior to its acquisition
by Hospira. These roles encompassed the development and commercialisation of pharmaceuticals, devices,
biologics and cellular therapies. Prior to this, Dr Oldham was an engagement manager with McKinsey &
Co (1997–2001). Tim has been Chairman of the European Generic Medicines Association Biosimilars and
Biotechnology Committee, a Director of the Generic Medicines Industry Association and a member of the
Pharmaceutical Industry Strategy Group. He is also a Director of Respiri Ltd (ASX: RSH) and a member of
AusBiotech’s Regenerative Medicine Advisory Group.
G Brooke
Director since
1 June 2016
Responsibilities
Non-Executive Director, member of the Audit and Risk Committee
Qualifications
MBBS, MBA
Experience
Geoff joined the board in June 2016. He founded GBS Venture Partners in 1996 and has more than 20 years’
venture capital experience. In January 2014, he reduced his involvement in GBS and is now Special Adviser to
the firm and its funds. Geoff was formally President of Medvest Inc., a US-based early-stage venture capital
group he founded with Johnson & Johnson. Geoff’s experience includes company formation and acquisitions,
as well as public listings on the NYSE, NASDAQ and ASX exchanges. He has been a founder, Executive and
Director of private and public companies and has an extensive international network. Geoff was formerly
on the board of two GBS portfolio companies. From 2009 until 2015, he was an independent Director of
the Victoria WorkCover Authority. Dr. Geoff Brooke is licensed in clinical medicine by the Medical Board of
Victoria, Australia and his post-graduate work was in anaesthetics/intensive care. He earned his Bachelor
of Medicine/Surgery from the University of Melbourne, Australia and a Masters of Business Administration
from IMEDE (now IMD) in Lausanne, Switzerland.
ACRUX ANNUAL REPORT 2016 23